Downsizing of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II), with the maintenance of anti-HIV activity and solution structure.

Source:http://linkedlifedata.com/resource/pubmed/id/9597190

Download in:

View as

General Info

PMID
9597190